In another study, treatment of acute-on-chronic liver failure (ACLF) mice with VISTA agonist suppressed T cell activation and cytokine production, considerably reducing mortality and liver inflammation in the mice (25). This evidence concerns the gene VSIR and acute-on-chronic liver failure.